• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Chewy Inc.

    6/25/25 4:05:19 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $CHWY alert in real time by email
    8-K
    false 0001766502 0001766502 2025-06-20 2025-06-20
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of Earliest Event Reported): June 20, 2025

     

     

    CHEWY, INC.

    (Exact Name of Registrant as Specified in Its Charter)

     

     

     

    Delaware   001-38936   90-1020167

    (State or Other Jurisdiction

    of Incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    7700 West Sunrise Boulevard,

    Plantation, Florida

      33322
    (Address of Principal Executive Offices)   (Zip Code)

    (786) 320-7111

    (Registrant’s Telephone Number, Including Area Code)

    N/A

    (Former Name or Former Address, if Changed Since Last Report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

      ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

      ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

      ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

      ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange

    on which registered

    Class A Common Stock, par value $0.01 per share   CHWY   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 1.01 Entry into a Material Definitive Agreement.

    Secondary Offering

    On June 23, 2025, Chewy, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Buddy Chester Sub LLC (the “Seller”), an entity affiliated with funds advised by BC Partners PE LP (“BC Partners”) and J.P. Morgan Securities LLC (the “Underwriter”), relating to the offer and sale by the Seller of 23,952,096 shares of Class A common stock, par value $0.01 per share, of the Company (the “Class A Common Stock”), at a price to the public of $41.95 per share (the “Offering”). In addition, the Seller granted the Underwriter a 30-day option (the “Option”) to purchase up to an additional 3,592,815 shares of Class A Common Stock. On June 24, 2025, the Option was exercised by the Underwriter substantially in full. The Company did not sell any shares of Class A Common Stock in the Offering and did not receive any proceeds from the sale of the shares offered by the Seller. The Offering closed on June 25, 2025.

    The Underwriting Agreement contains customary representations and warranties, agreements and obligations, closing conditions and termination provisions. The Company and the Seller have agreed to indemnify the Underwriters against certain liabilities and to contribute to payments the Underwriters may be required to make in the event of any such liabilities.

    The foregoing description of the Underwriting Agreement does not purport to be complete and is subject to and is qualified in its entirety by reference to the Underwriting Agreement, a copy of which is attached hereto as Exhibit 1.1 and the terms of which are incorporated herein by reference.

    Kirkland & Ellis LLP has issued an opinion, dated June 25, 2025, regarding certain legal matters with respect to the Offering, a copy of which is filed as Exhibit 5.1 hereto.

    Stock Repurchase

    On June 20, 2025, the Company entered into an agreement (the “Stock Repurchase Agreement”) with the Seller, to purchase $100 million of shares of Class A Common Stock from the Seller, at a price per share equal to the per share purchase price paid by the Underwriter in the Offering specified above (the “Stock Repurchase”). The Stock Repurchase Agreement contains customary representations, warranties and covenants of the parties. The Stock Repurchase closed on June 25, 2025 and in connection therewith the Company repurchased 2,395,210 shares of Class A Common Stock from the Seller. These repurchased shares have been cancelled and retired.

    A special committee of the Board of Directors of the Company (the “Board”), consisting solely of independent directors not affiliated with BC Partners or the Seller, pursuant to authority delegated to it by the Board, approved the Stock Repurchase. The Board, acting on the recommendation of the special committee, approved the Stock Repurchase without utilizing capacity under the Company’s existing share repurchase program.

    The foregoing description of the Stock Repurchase Agreement does not purport to be complete and is subject to and is qualified in its entirety by reference to the Stock Repurchase Agreement, a copy of which is attached hereto as Exhibit 10.1 and the terms of which are incorporated herein by reference. For more information on BC Partners’ relationship to the Company, please refer to the Company’s Definitive Proxy Statement filed on May 23, 2025.

    Item 9.01 Financial Statements and Exhibits.

    (d) Exhibits.

     


    Exhibit No.    Description
    1.1    Underwriting Agreement, dated as of June 23, 2025, by and among Chewy, Inc., Buddy Chester Sub LLC and J.P. Morgan Securities LLC
    5.1    Opinion of Kirkland & Ellis LLP, relating to the Offering.
    10.1    Stock Repurchase Agreement, dated June 20, 2025 by and between Chewy, Inc. and Buddy Chester Sub LLC.
    104    The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

                CHEWY, INC.
    Date: June 25, 2025     By:  

    /s/ Da-Wai Hu

          Da-Wai Hu
          General Counsel and Secretary
    Get the next $CHWY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CHWY

    DatePrice TargetRatingAnalyst
    6/9/2025$47.00Outperform → Neutral
    Mizuho
    6/5/2025$43.00Buy → Hold
    Jefferies
    3/24/2025Neutral
    Seaport Research Partners
    1/23/2025Hold → Buy
    Argus
    1/13/2025$34.00 → $47.00In-line → Outperform
    Evercore ISI
    1/6/2025$24.00 → $42.00Neutral → Outperform
    Mizuho
    1/3/2025Peer Perform → Outperform
    Wolfe Research
    12/5/2024Outperform → Neutral
    Exane BNP Paribas
    More analyst ratings